BIOMAT Database Logo BIOMAT Database Logo

Initial immunosuppression and managing rejection. 2019

Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Department of Respiratory Medicine, Hannover Medical School, 30623, Hannover, Germany. fuehner.thomas@mh-hannover.de.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D060828 Induction Chemotherapy Initial drug treatment designed to bring about REMISSION INDUCTION. It is typically a short-term and high-dose drug treatment that is followed by CONSOLIDATION CHEMOTHERAPY and then MAINTENANCE CHEMOTHERAPY. Chemotherapies, Induction,Chemotherapy, Induction,Induction Chemotherapies

Related Publications

Thomas Fuehner, and Christian Benden, and Jens Gottlieb
[Rejection and immunosuppression].
October 1996, Gastroenterologia y hepatologia,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Chronic rejection and suboptimal immunosuppression.
April 1993, Transplantation proceedings,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Immunosuppression and rejection in liver transplantation.
April 1993, Transplantation proceedings,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Rejection and immunosuppression in kidney transplantation.
November 1979, Journal of clinical & laboratory immunology,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Managing the risks of immunosuppression.
June 2011, Current opinion in neurology,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Managing immunosuppression in medical patients.
July 2009, British journal of hospital medicine (London, England : 2005),
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Immunosuppression and rejection in human hand transplantation.
March 2009, Transplantation proceedings,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation.
June 2023, Journal of hepatology,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
Calcineurin Inhibitor-Based Maintenance Immunosuppression in Lung Transplant Recipients: Optimal Serum Levels for Managing Acute Rejection and Renal Function.
January 2021, Transplantation proceedings,
Thomas Fuehner, and Christian Benden, and Jens Gottlieb
[Graft rejection reaction and immunosuppression following heart transplantation].
February 1990, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!